Human Corneal Endothelial Cells

Primary human corneal endothelial cells (HCECs) form the single layer of neuroectoderm-derived cells that lines the posterior surface of the cornea. In vivo, these post-mitotic cells are essential for maintaining corneal transparency through a “pump-leak” mechanism. Primary HCECs, isolated from donor tissue and cultured under optimized conditions, recapitulate this specialized physiology in vitro, providing a faithful human model of the corneal endothelium.

A key strength of primary HCECs is their capacity to establish a fully differentiated, contact-inhibited monolayer with characteristic polygonal, often hexagonal, morphology. They organize robust apicolateral tight junctions, visualized by continuous ZO-1 localization, and uniformly express the defining endothelial markers Na⁺/K⁺-ATPase, aquaporin-1, N-cadherin, and collagen VIII, while remaining negative for corneal epithelial keratins. Functionally, these cells generate a measurable transendothelial electrical resistance and actively transport ions and fluid, thereby mirroring the deturgescence pump critical for corneal clarity. Their human provenance eliminates species-dependent confounders, enabling direct investigation of endothelial dystrophies such as Fuchs endothelial corneal dystrophy, assessment of drug-induced toxicity, and development of tissue-engineered grafts. Notably, supplementation with Rho-associated kinase (ROCK) inhibitors now permits transient expansion of primary HCECs without sacrificing differentiated function, overcoming their inherently limited proliferative capacity and opening avenues for cell-based regenerative therapy.